Be Seen – Get Involved
ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma and biotechnology industry professionals who need to know what’s going on in drug delivery.
ONdrugDelivery’s readers have a predefined commercial interest in drug delivery – gain a presence in ONdrugDelivery to engage with them.
How to gain a presence in ONdrugDelivery
If your company’s activities are a fit with ONdrugDelivery’s specialist topics, and you need to access, engage and generate qualified leads from ONdrugDelivery’s readers, there are various ways of gaining a presence:
1. BECOME AN ISSUE SPONSORSponsorship in ONdrugDelivery is our tried-tested-and-trusted powerful and effective method of not only getting your message across in full to the people you want to reach, but to yield tangible results by engaging with them. The ONdrugDelivery sponsorship package – designed specifically to grab the attention of your potential partners and clients – is an intelligent combination of advertising, branding and editorial which serves to:
Magazine Benefits of Issue Sponsorship
|
Non-Promotional Editorial Content
We welcome proposals for non-promotional article contributions. Not associated with advertising or sponsorship, these unbranded, non-paid submissions are of the highest quality and are written by recognised experts in the field. We call these articles Expert Views and Early Insights. Please Contact us to find out more.
|
|
3. ADVERTISINGMagazine Advertisements ONdrugDelivery Magazine can carry double-page spread, full-page, half-page vertical, half-page horizontal, third-of-a-page vertical (one col) and third-of-a-page horizontal advertisements. All ads are colour, by default they are right-hand-page positioned. Specific positioning requirements can always be considered.
Web Banner Advertisements Our digital advertising offering is focused on quality. Strictly limited positions are available and artwork with style and of a high standard is required. This ensures maximum quality, engagement, impact and value both of the website experience for our readers and of the space our advertisers purchase. A limited number of Leaderboard (728x90px) and Skyscraper (120x600px) web ad positions, linking to a URL of your choice (including a tracking URL if desired), with various page-specific positioning options (including specific drug-delivery topic-targeted options) are available for 3 month, 6 month and 12 month runs.
|
Contact us today to begin a conversation about transforming your organisation’s B2B marketing and business development performance to drive new sales and partnerships, by featuring your organisation in ONdrugDelivery.
Drug delivery is a global industry, ONdrugDelivery’s readership is global, and our reach is global. However, Frederick Furness Publishing is a family owned, highly customer-focused company dealing with niche topics. As such, we have a detailed knowledge of the drug delivery business and a very personal approach to meeting the needs of our sponsors and advertisers.
ONdrugDelivery can help your organisation boost its business development and partnering success!
Find out today how your company can benefit from reaching and engaging ONdrugDelivery’s readers by contacting Guy Furness, ONdrugDelivery’s Founder and Publisher:
Guy Furness
T: +44 1273 47 28 28
E: [email protected]
ONdrugDelivery has an excellent reputation, regular loyal support from leading companies (from the very largest to the very smallest), and a global, engaged, combined print and digital readership.
Each issue of ONdrugDelivery is published:
1. In print and PDF
2. In a monthly email alert / e-newsletter
3. Online on our website.
4. Via social media (LinkedIn, Twitter and Facebook).
Increasing our global reach and impact further still, we were selected by Elsevier to be indexed on their Scopus and Embase databases – two of the world’s largest and best regarded scientific literature search tools.
Readership is truly global – core readership geographically predominantly North American and European with a substantial proportion of readers throughout the world’s other major pharma markets (Japan, Israel, Australia, New Zealand and others), and notably a rapidly increasing number in the fast-growing Asian and South American markets.
By job function, most of the readership comprises middle and senior decision makers (executives and scientists) working within the global pharmaceutical, biotechnology, specialty pharma, drug delivery and medical devices industries. (Regulators, academics, financial analysts, consultants and bankers are also among our readers.)
ONdrugDelivery’s core global Print +Digital readership, wide social media reach, being indexed in top scientific literature database, and extensive yet topic-focused bonus print conference distribution combine to make a compelling, tightly targeted, truly global promotional value proposal.
In which issues should your company appear?
There are between 10 and 12 issues published per year. For companies providing drug delivery-related products, technologies and services, the publications provide a platform from which to reach new clients and partners. The high level of topic specificity gives an unparalleled degree of targeting.
Issue topics include:
- Connecting Drug Delivery
- Industrialising Drug Delivery
- Injectable Drug Delivery (Formulations and Devices)
- Novel Oral Delivery Systems
- Ophthalmic Drug Delivery
- Pulmonary & Nasal Drug Delivery
- Prefilled Syringes & Injection Devices
- Skin Drug Delivery: Dermal, Transdermal and Microneedles
- Wearable Injectors
See what ondrugdelivery's readers and contributors think
ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.
I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.
I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.
Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.